An online health brand can build a beautiful funnel, source product, and run paid acquisition profitably — and still be unable to ship a single order. The bottleneck is almost never marketing. It is that a licensed provider has to evaluate every patient, in the state that patient is sitting in, before anything is prescribed.
That is what a nationwide provider network is for. Here is what one actually has to do to work.
The constraint: licensure follows the patient
A provider must be licensed where the patient is physically located at the time of the encounter — not where your company is incorporated, not where your pharmacy sits, not where the provider lives.
So a brand selling in 40 states needs providers licensed across those 40 states. Not one heroic physician with a wall of licenses, but enough coverage that every order has an eligible reviewer, at volume, every day, including the day someone’s license is up for renewal.
This is the reason most DTC health brands stall. Building it in-house means recruiting, credentialing, and maintaining a multi-state provider panel — a recurring operations function, not a launch task.
What the review actually is
Every order needs a real clinical evaluation — commonly a good faith exam. The provider reviews history, medications, allergies, and contraindications, and decides whether the requested treatment is appropriate.
The decision has to be able to go either way. A review process that approves everything is not a review process, and it is the first thing that looks wrong when someone examines your operation. Real networks produce declines, and the decline rate is a health metric, not a conversion problem.
Synchronous, asynchronous, and where the line falls
| Modality | What it means | Where it applies |
|---|---|---|
| Asynchronous | Provider reviews an intake and record without a live encounter | Permitted in many states for many treatment categories |
| Synchronous audio-video | Live visit | Required by some states, and for some drug classes |
| Controlled substances | Federal rules apply on top of state telehealth law | Stricter; do not assume state permission is sufficient |
The rules vary by state and by what is being prescribed. A network that applies one policy nationwide is either over-restricting and losing volume, or under-restricting and creating exposure.
What a functioning network has to deliver
- State coverage that matches your market, with a credentialing pipeline that keeps up with expansion
- Routing that respects licensure — the order goes to a provider eligible for that patient’s state, automatically
- Turnaround you can build a customer experience around, with predictable behaviour under load
- A real decline path, including how the patient is told and what happens to their payment
- Documentation that survives review — who evaluated, when, on what basis, in which state, under what modality
- Escalation when a case needs a second look
- Pharmacy integration so an approval becomes an actual prescription
The part most brands underestimate
Payment timing. If you charge before a provider has reviewed, you will approve refunds for every decline, and you have created pressure — visible to anyone reviewing your operation — to approve rather than decline.
The cleaner pattern is to authorize and capture on approval, so the clinical decision is never standing between the company and revenue it has already taken.
Build or partner
Building in-house is viable at scale, and it is a permanent function: recruiting, credentialing, license renewals, malpractice, protocol maintenance, quality review, and the software to route and document all of it.
Partnering moves that to a group that already has the panel and the infrastructure. The trade is control and margin against speed and a lower fixed cost. Most brands should partner until volume justifies owning it.
What MDside provides
MDside operates the clinical layer for online health brands: a licensed provider network, good faith exam and review workflow, prescribing integrations, and the professional entity structure underneath — running on software we build and own rather than license from a vendor who can reprice it or sell to your competitor.
Your brand stays yours. See what is included, or read how good faith exams work.
Frequently asked questions
Do I need providers licensed in every state I sell to?
Yes. Licensure follows the patient’s location at the time of the encounter. Selling into a state without an eligible provider is not something a disclaimer fixes.
Can the evaluation be asynchronous?
In many states and for many treatment categories, yes. Some states and some drug classes require live audio-video, and controlled substances carry separate federal requirements.
How fast should review turnaround be?
Fast enough that customers do not abandon, and consistent enough to build an experience around. Consistency under load matters more than the headline number.
What happens when a patient is declined?
They should be told clearly, not charged for a treatment they are not receiving, and pointed toward an appropriate next step. Declines are evidence the process is real.
Who holds the patient records?
The professional entity that employs or contracts the providers — not the marketing brand. Records custody is one of the clearest signals of whether the separation is genuine.
General information about multi-state telehealth operations, not legal advice. Telehealth modality rules, licensure requirements, and controlled substance regulations vary and change. Confirm with healthcare counsel.